S&P 5007,757▲ 0.58%Nasdaq26,703▲ 1.05%Dow Jones52,856▲ 0.69%Nasdaq 10029,823▲ 1.13%VIX16.68▼ 3.64%US Dollar101.69▼ 0.01%Gold spot4,114▼ 0.44%WTI spot101.91▲ 1.04%
Home › EU › Research report
← EU page
XStocksXray
Market X-Ray report · 21 October 2026

enCore Energy Corp. (EU)

TSX Venture Exchange · Canada · prices in CAD · close of 21 Oct 2026

Key indicators

Last closeCAD 1.160
52-week range1.042 – 4.817
Return, 1 month / 3 months−20.9% / −29.7%
Return, 1 year / 3 years−73.7% / −71.9%
TrendBelow its 200-day average
RSI (14)37
Volatility (1 year)89.2%
Worst drawdown (1 year)-75.7%
Average daily value traded0.89M CAD
Dividend yield–

Market X-Ray price-based

32/ 100 · High confidence · ahead of 23% of stocks on this exchange
Trend8
Momentum11
Stability (higher is calmer)37
Liquidity98
Income–

Five-year price chart navy: price · brown: 200-day average

0.812.343.875.396.922021-102023-012024-042025-072026-10

About the company

enCore Energy Corp. is a uranium company based in Corpus Christi, Texas, focused on producing uranium for the nuclear power industry. It uses in-situ recovery methods to extract uranium from sandstone-hosted deposits, mainly in South Texas, and also holds processing facilities and exploration properties in the United States. Its customers are utilities and other buyers of nuclear fuel, and its activities centre on supplying domestic uranium to the American market.

The shares are listed on the TSX Venture Exchange in Canada under the code EU, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

enCore Energy Corp. (EU) trades on the TSX Venture Exchange in Canada. It last closed at CAD 1.160 on 21 October 2026.

Its price-based Market X-Ray is 32 out of 100 (a weak price profile), ranking 1,159 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 73.7% and over the last three months it fell 29.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
enCore Energy Corp. (EU)

The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange

Lens and metricValueScoreReading
Trend8 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-50.2%
From 52-week high-75.3%
Momentum11 · WeakLagging most stocks on this exchange.
3-month return-29.7%
6-month return-55.5%
12-month return, skipping the last month-66.7%
Stability (higher is calmer)37 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)89.2%
Worst drawdown, 1 year (smaller is calmer)-75.7%
Liquidity98 · StrongTrades actively.
Average daily value traded0.89M CAD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.3%
1 month−20.9%
3 months−29.7%
6 months−55.5%
1 year−73.7%
3 years−71.9%
5 years–

Signals

50-day / 200-day average1.517 / 2.329
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.115

Technical summary

DailyStrongly bearish3 bullish · 1 neutral · 12 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 21 Oct 2026